California State Teachers Retirement System Karuna Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$80.4 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$161.01 - $317.85 $261,963 - $517,141	-1,627 Reduced 4.51%	34,434 $10.9 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $359,288 - $475,850	-2,182 Reduced 5.71%	36,061 $6.1 Million
Q2 2023 Aug 21, 2023	BUY	$176.32 - $240.22 $358,634 - $488,607	2,034 Added 5.62%	38,243 $8.29 Million
Q1 2023 May 09, 2023	BUY	$161.33 - $204.36 $139,389 - $176,567	864 Added 2.44%	36,209 $6.58 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $111,278 - $137,592	581 Added 1.67%	35,345 $6.95 Million
Q3 2022 Nov 18, 2022	BUY	$123.79 - $277.42 $555,569 - $1.25 Million	4,488 Added 14.82%	34,764 $7.82 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $278,057 - $424,113	2,959 Added 10.83%	30,276 $3.83 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $226,678 - $303,392	-2,292 Reduced 7.74%	27,317 $3.46 Million
Q4 2021 Feb 15, 2022	BUY	$110.64 - $159.4 $81,873 - $117,956	740 Added 2.56%	29,609 $3.88 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $175,480 - $218,258	-1,734 Reduced 5.67%	28,869 $3.53 Million
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $728,725 - $922,012	6,782 Added 28.47%	30,603 $3.49 Million
Q1 2021 May 18, 2021	SELL	$95.46 - $133.08 $9,068 - $12,642	-95 Reduced 0.4%	23,821 $2.86 Million
Q3 2020 Nov 17, 2020	BUY	$71.31 - $109.74 $38,008 - $58,491	533 Added 2.28%	23,916 $1.85 Million
Q2 2020 Aug 17, 2020	BUY	$62.14 - $117.21 $461,451 - $870,401	7,426 Added 46.54%	23,383 $2.61 Million
Q1 2020 May 13, 2020	BUY	$60.41 - $115.92 $532,937 - $1.02 Million	8,822 Added 123.64%	15,957 $1.15 Million
Q3 2019 Nov 15, 2019	BUY	$16.05 - $27.35 $114,516 - $195,142	7,135 New	7,135 $116,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account